Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

TSX Venture Exchange approves Advitech's issued and outstanding common shares

TSX Venture Exchange approves Advitech's issued and outstanding common shares

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Positive Phase II/III clinical data from ChemoCentryx' PROTECT-1 Traficet-EN trial

Positive Phase II/III clinical data from ChemoCentryx' PROTECT-1 Traficet-EN trial

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Book on pediatric IBD launched

Book on pediatric IBD launched

Johns Hopkins University to create a Human Proteome Chip using Arrayit's technology

Johns Hopkins University to create a Human Proteome Chip using Arrayit's technology

4SC raises funds for further development of its current product pipeline

4SC raises funds for further development of its current product pipeline

Self-care tips for hemorrhoids from Mayo Clinic

Self-care tips for hemorrhoids from Mayo Clinic

Research team identifies five new gene regions that raise the risk of childhood-onset IBD

Research team identifies five new gene regions that raise the risk of childhood-onset IBD

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Pharmos announces financial results for the third quarter of 2009

Pharmos announces financial results for the third quarter of 2009

William D. Carey Award for Boston University School of Medicine professor

William D. Carey Award for Boston University School of Medicine professor

GI and hepatology societies take initiative to evaluate the current medical school curriculum

GI and hepatology societies take initiative to evaluate the current medical school curriculum

Online resource to illustrate genetic networks in common autoimmune diseases published

Online resource to illustrate genetic networks in common autoimmune diseases published

AMT inks agreement with Progenika Biopharma for development of LPLchip

AMT inks agreement with Progenika Biopharma for development of LPLchip

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.